STK3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.699400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.635000E-01
Normal-vs-Stage2
3.327000E-01
Normal-vs-Stage3
8.893600E-01
Normal-vs-Stage4
3.406600E-01
Stage1-vs-Stage2
4.483200E-01
Stage1-vs-Stage3
6.926800E-01
Stage1-vs-Stage4
3.082800E-01
Stage2-vs-Stage3
3.444600E-01
Stage2-vs-Stage4
5.850000E-01
Stage3-vs-Stage4
3.336800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.830400E-01
Normal-vs-AfricanAmerican
3.720600E-01
Normal-vs-Asian
5.378000E-01
Caucasian-vs-AfricanAmerican
9.351200E-01
Caucasian-vs-Asian
5.183400E-01
AfricanAmerican-vs-Asian
5.635800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.800400E-01
Normal-vs-Female
3.678000E-01
Male-vs-Female
9.688400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.808200E-01
Normal-vs-Age(41-60Yrs)
1.611050E-01
Normal-vs-Age(61-80Yrs)
5.118600E-01
Normal-vs-Age(81-100Yrs)
4.892600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.671370E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.281800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.997000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.043300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.750300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.400600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.223400E-01
Normal-vs-Daily Drinker
5.267200E-01
Normal-vs-Weekly Drinker
4.825000E-01
Normal-vs-Occasional Drinker
2.446800E-01
Normal-vs-Social Drinker
4.177000E-01
Non Drinker-vs-Daily Drinker
8.583000E-01
Non Drinker-vs-Weekly Drinker
3.702600E-01
Non Drinker-vs-Occasional Drinker
2.748800E-01
Non Drinker-vs-Social Drinker
7.254800E-01
Daily Drinker-vs-Weekly Drinker
5.670400E-01
Daily Drinker-vs-Occasional Drinker
2.686600E-01
Daily Drinker-vs-Social Drinker
8.805800E-01
Weekly Drinker-vs-Occasional Drinker
7.988100E-02
Weekly Drinker-vs-Social Drinker
6.442400E-01
Occasional Drinker-vs-Social Drinker
1.965000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.251000E-01
Normal-vs-Grade 2
8.652300E-02
Normal-vs-Grade 3
8.859800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.784400E-03
Grade 1-vs-Grade 3
2.901000E-03
Grade 1-vs-Grade 4
4.251000E-01
Grade 2-vs-Grade 3
1.495390E-01
Grade 2-vs-Grade 4
8.652300E-02
Grade 3-vs-Grade 4
8.859800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.759200E-01
Normal-vs-NonDiabetic
3.383000E-01
Diabetic-vs-NonDiabetic
1.445000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.762010E-01
Normal-vs-NoPancreatitis
3.915400E-01
Pancreatitis-vs-NoPancreatitis
8.638000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.264000E-01
Normal-vs-N1
2.965800E-01
N0-vs-N1
1.161820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.083620E-01
Normal-vs-TP53-NonMutant
8.077800E-01
TP53-Mutant-vs-TP53-NonMutant
2.40969999953933E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
